| Literature DB >> 19412374 |
.
Abstract
Transmission of infection in the paediatric office is of increasing concern. The present document discusses routes of transmission of infection and the principles of current infection control measures. Prevention includes appropriate office design and administrative policies, triage, routine practices for the care of all patients (eg, hand hygiene; use of gloves, masks, eye protection and gowns for specific procedures; adequate cleaning, disinfection and sterilization of surfaces and equipment including toys, and aseptic technique for invasive procedures), and additional precautions for specific infections. Personnel should be adequately immunized, and those infected should follow work-restriction policies.Entities:
Keywords: Ambulatory; Infection control; Infection transmission; Paediatric office
Year: 2008 PMID: 19412374 PMCID: PMC2532878
Source DB: PubMed Journal: Paediatr Child Health ISSN: 1205-7088 Impact factor: 2.253
Illnesses warranting Additional Precautions*
| Infection | Precautions | Duration of precautions |
|---|---|---|
| Antibiotic-resistant organisms (infection or colonization) | Contact | If patients assessed as at risk to transmit (see text) |
| Avian influenza | Droplet plus Contact | To 14 days from onset |
| Enteroviral infection (diagnosed or suspected) | Contact | Duration of illness |
| Gastroenteritis | Contact | Duration of symptoms or until infectious cause ruled out |
| Hepatitis, viral (types A and E, diagnosed or suspected) | Contact | Until viral infection ruled out; to 7 days after onset if hepatitis A |
| Measles (diagnosed or suspected) | Airborne | To 4 days after onset of rash (duration of illness if immunocompromised) |
| Measles contact, nonimmune, in incubation period | Airborne | From 5 days after the first day of exposure to 21 days after the last day of exposure |
| Meningitis (diagnosed or suspected | Droplet plus Contact | |
| Bacterial | Droplet | Until 24 h of appropriate antibiotic received |
| Viral | Contact | Duration of illness |
| Mumps | Droplet | To 9 days after onset of swelling |
| Mumps contact, nonimmune, in incubation period | Droplet | From 10 days after the first day of exposure to 26 days after the last day of exposure |
| Pertussis (diagnosed or suspected) | Droplet | Until 5 days of appropriate antibiotic received or pertussis ruled out |
| Petechial or ecchymotic rash with fever (suspected meningococcemia) | Droplet | Until 24 h of appropriate antibiotic received or meningococcus ruled out |
| Rubella | Droplet | To 7 days after onset of rash |
| Rubella contact, nonimmune, in incubation period | Droplet | From 7 days after the first day of exposure to 21 days after last day of exposure |
| SARS | Droplet plus Contact plus N95 masks | 10 days after resolution of fever |
| Scabies (diagnosed or suspected) | Contact | Until initial therapy applied |
| Skin infection (extensive lesions, abscess or infected wound if drainage or exudate not covered or contained by dressing) | Contact | Duration of drainage or until lesions healed |
| Streptococcus group A impetigo not covered by dressing | Contact | Until 24 h of appropriate therapy received |
| Streptococcus group A invasive disease, pharyngitis, pneumonia, scarlet fever | Droplet | Until 24 h of appropriate antibiotic received |
| Tuberculosis (diagnosed or suspected) infectious form | Airborne | Until assessed as not infectious |
| Varicella (diagnosed or suspected) | Airborne plus Contact | Until lesions crusted or varicella ruled out |
| Varicella contact, nonimmune, in incubation period | Airborne | From 8 days after the first day of exposure to 21 days after the last day of exposure; to 28 days if given varicella zoster immune globulin |
| Viral respiratory tract infection (diagnosed or suspected – bronchiolitis, cold, croup, pneumonia, pharyngitis) | Droplet plus Contact | Duration of illness or until viral infection ruled out |
| Zoster (diagnosed or suspected) – not covered | Airborne and Contact | Until lesions crusted or zoster ruled out |
This list is not exhaustive. For infections not listed here, see tables in references 1 and 4;
These recommendations may be revised as more information becomes available. Local, provincial or federal authorities should be consulted;
Tuberculosis should be considered to be contagious in those with untreated cavitary pulmonary disease, laryngeal disease, smear-positive sputum, extensive lung involvement or disseminated congenital infection. Young children with tuberculosis are rarely infectious, but adult family members may be and should be assessed for cough. SARS Severe acute respiratory syndrome. Data from references 1,4,38,55–57
Sterilization and disinfection requirements
| Instrument | Level of disinfection | Products |
|---|---|---|
| Critical items – items that enter sterile tissue (eg, needles) | Sterilization | Steam, dry heat, chemical sterilants |
| Semicritical items – items that contact mucous membranes or nonintact skin but do not enter tissue (eg, laryngoscopes, specula) | Sterilization or high-level disinfection | Pasteurization, 2% glutaraldehyde, 0.55% orthophthalaldehyde, 6% to 7.5% hydrogen peroxide with or without peracetic acid, immersion in sodium hypochlorite 5.25% diluted 1:50 for ≥20 min, immersion in boiling water for 20 min |
| Noncritical items | Intermediate-or low-level disinfection. Detergent and water considered sufficient by some authorities | 70% to 90% ethyl or isopropyl alcohol, sodium hypochlorite 5.25% diluted 1:500, 3% hydrogen peroxide, quaternary ammonium products, iodine, iodophors, 0.5% accelerated hydrogen peroxide, phenolics |
| Environmental surfaces – doorknobs, table tops, carts, floors | Low-level disinfection or detergent and water |
If visibly contaminated with blood, use sodium hypochlorite diluted 1:10 to 1:100 or 70% to 90% alcohol;
Phenolics should not be used for items that will be in direct contact with the skin of newborns. Data from references 2,3,5,6,40,41,59
Work restrictions for health care providers
| Infection | Restriction | Duration |
|---|---|---|
| Blood-borne viruses: (Hepatitis B and C, HIV) | From performing specific exposure-prone procedures at high risk of transfer of blood ( | As per local public health policy (viremia resolved or blood viral load controlled) |
| Colds, other viral upper respiratory tract infections | From direct care of high-risk patients | Until symptoms resolved |
| Conjunctivitis | From direct patient care | Until exudate resolved |
| Gastroenteritis | From direct patient care | Until symptoms resolved or illness deemed noncontagious |
| Hepatitis A | From direct patient care | Until one week after onset of jaundice |
| Herpes simplex, orofacial | From direct care of newborns and nonimmune immunocompromised patients if lesions not covered | Until lesions dry |
| Herpetic whitlow | From direct patient care | Until lesions dry |
| Influenza | From office | Until symptoms resolved |
| Measles | From office | Until four days after onset of rash |
| Mumps | From office | Until nine days after onset of parotitis |
| Pediculosis | From direct patient care | Until one treatment completed (<24 h) |
| Pertussis | From office | Until five days of appropriate antibiotic |
| Rubella | From office | Seven days after onset of rash |
| Scabies | From direct patient care | Until one treatment completed (<24 h) |
| Staphylococcal skin infection (MSSA) | From direct patient care if
| Until lesions on hands are healed Until lesions elsewhere can be covered by dressings |
| Staphylococcal skin infection (MRSA) | From direct patient care | Until lesions healed and assessed for risk of transmission |
| Streptococcus group A infection | From direct patient care | Until treated for 24 h |
| Tuberculosis, active pulmonary | From office | Until assessed as noninfectious |
| Varicella | From office | Until lesions crusted |
| Zoster | From direct patient care if not covered. If covered: From care of newborns and nonimmune immunocompromised patients and pregnant women | Until lesions crusted |
Patients with hemodynamically significant congenital heart disease or chronic lung disease, neonates and immunocompromised patients;
Clinically significant diarrhea or vomiting;
If working, keep lesions covered, avoid touching face during patient care, wear surgical or procedure mask during care and wash hands after touching lesions and before touching any patient or patient care equipment. MRSA Methicillin-resistant Staphylococcus aureus; MSSA Methicillin-susceptible S aureus. Data from references